Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: EcoR1 Capital and Dicerna Pharmaceuticals Inc (DRNA)

Page 2 of 7 – SEC Filing

1. Names of Reporting Persons.

EcoR1 Capital, LLC

2. Check the Appropriate Box if
a Member of a Group (See Instructions)

(a) X

(b)

3. SEC Use Only
4. Citizenship or Place of Organization Delaware
Number of
Shares
Beneficially
Owned by
Each Reporting
Person With:
5. Sole Voting Power -0-
6. Shared Voting Power 4,836,547
7. Sole Dispositive Power -0-
8. Shared Dispositive Power 4,836,547
9. Aggregate Amount Beneficially Owned by Each Reporting Person 4,836,547
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ______
11. Percent of Class Represented by Amount in Row (9) 9.4%
12. Type of Reporting Person (See Instructions) OO
Follow Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)
Trade (NASDAQ:DRNA) Now!
Loading...